Mission + Values
|
Our Story
|
About ALS
|
Our People
|
Our Sponsors
|
Financial Reports
<table width="100%" border="0" cellspacing="0" cellpadding="0" bgcolor="#FFFFFF"> <tr> <td><span class=default> <!-- startprint --> <span class=default><p>Prize4Life is fortunate to partner with the Harvard Business School's Board Fellows program. Participants in the Fellows program join the Boards of non-profit organizations as non-voting members, contributing their expertise and strengthening the connection between HBS and the Boston non-profit community. Past and present Fellows:</p> <p><strong>2009-2010</strong></p> <p><strong>ERIN BARRINGER</strong></p> <p>A 2009-2010 Board Fellow, Ms. Erin Barringer is currently a student at the Harvard Business School. Prior to HBS, Erin worked as Consultant at Dalberg Global Development Advisors, offering strategy consulting advice to global health organization. Before Dalberg, Erin worked as a Consultant at IMS consulting, offering strategy consulting advice to pharmaceutical and biotechnology companies. Erin has a B.A. in History of Science from Harvard University.</p> <p><strong>ROBERT JANG </strong></p> <p>A 2009-2010 Board Fellow, Mr. Robert Jang is currently a student at the Harvard Business School. Prior to HBS, Robert worked as an Associate at The Carlyle Group (U.S. Buyout Fund) focusing on healthcare investments. Before Carlyle, Robert worked as an Analyst at Merrill Lynch in its Mergers & Acquisition group. Robert has a B.A. in Economics-Political Science from Columbia University. </p> <p><strong>ELIA PINEIRO </strong></p> <p>A 2009-1010 Board Fellow, Ms. Elia Pineiro is a student and research associate at the Harvard Business School. She is currently working with HBS faculty on an international healthcare case, CEO Time Study and New CEO Workshop. Prior to HBS, Elia was a pharmaceutical sales representative with Sanofi-Aventis. After business school, she hopes to re-enter the pharmaceutical/biotechnology industry in a strategy or business development position.</p> <p><strong>2008-2009</strong></p> <p><strong>ALLISON KOTZIN</strong></p> <p>Ms. Allison Kotzin was a Board fellow during her second year at the Harvard Business School. After graduation she joined the Genzyme corporation as part of the business development group. She was previously an associate for Morgan Stanley. Ms. Kotzin holds an A.B. from the Woodrow Wilson School of Public and International Affairs at Princeton University. Her father battled ALS for 20 years, which prompted her to seek out Avi and join the Prize4Life team. She has been instrumental in various development efforts for the organization.</p> <p><strong>SEAN MURRAY</strong></p> <p>Mr. Sean Murray was a Board Fellow as a first-year student at Harvard Business school. He has worked as a design engineer at orthopedic manufacturer Stryker, where he led a design team that produced a line of patent-pending disposable manifolds. Murray played baseball at the University of New Mexico and graduated as valedictorian of the School of Engineering. He was also one of 77 students in the United States awarded a Truman Scholarship in 2004 for leadership potential. He currently works for McKinsey & Company.</p> <p><strong>2007-2008</strong></p> <p><strong>ANDREW DERVAN</strong> </p> <p>Mr. Andrew Dervan was a Board Fellow as a second-year student at Harvard Business School. He has worked as a summer associate at 5am Ventures, an early stage healthcare venture capital firm, and as a business development intern at Pulmatrix, an aerosol therapeutics company. Andrew has also completed research at the Brigham and Women's Hospital in Boston and the University of Southern California School of Pharmacy in Los Angeles. His work has appeared in journals such as <em>Molecular and Cellular Biology</em> and the <em>Journal of Nursing Administration</em>. Andrew has a BA in biology from Yale University where he studied neuroscience. He is currently at Harvard Medical School where he is finishing his MD degree.<br> <br><strong>NIKITA GUJRAL</strong> <p>Ms. Nikita Gujral was a Board Fellow as a first year student at the Harvard Business School. She has worked as an analyst at Morgan Stanley, where she was one of two analysts selected and sponsored to work full-time for the 9/11 United Services Group, which coordinated and managed a network of over 40 human services agencies that collectively served over 85,000 people affected by the World Trade Center terrorist attacks. She has also worked as an associate at Azimuth Trust and at the Gordon E. and Betty I. Moore Foundation. Nikita earned a Bachelor of Business Administration from the University of Michigan Business School.</p> <p><strong>2006-2007</strong></p> <p><strong>PETER BOWEN</strong></p> <p>Mr. Peter Bowen is a Consultant at Bain & Company and a graduate of Harvard Business School, Class of 2007. His father was diagnosed with ALS in January of 2005, which prompted him to seek out Avi and join Prize4Life during his school years. He has volunteered with Prize4Life since 2006 and works to raise funds for ALS organizations including Prize4Life through a variety of charity events. He resides in Boston and did his undergraduate at Cornell University. </p> <p><strong>HARPREET SINGH</strong> </p> <p>Harpreet served as a Board Fellow from 2006-2007. Her commitment to ALS research stems from her's father's battle with ALS, which he lost in 1995. Harpreet's professional interests are the intersection between technology, social enterprise, and education. She currently works at Apple in product planning. Prior to business school, Harpreet worked as a strategy consultant with The Bridgespan Group, a strategy consulting firm affiliated with Bain & Company that is focused on social enterprise, and in international policy & development with the United Nations, CARE, and the Aga Khan Development Network. Harpreet has an MBA from MIT's Sloan School of Management, a Masters from Harvard University in International Education Policy and Bachelors from Duke University in Public Policy Studies and Economics.</p></span> <!-- stopprint --> </span></td> </tr> </table>
